title: Patient-Derived Xenografts for Investigation of Acquired Resistance in Oncogene-Driven Cancers: Building a Better Mousetrap.
authors.affiliation: University of California, Davis, Comprehensive Cancer Center, Sacramento, CA david.gandara@ucdmc.ucdavis.edu.
authors.forename: David R
authors.initials: DR
authors.lastname: Gandara
authors.affiliation: University of California, Davis, Comprehensive Cancer Center, Sacramento, CA.
authors.forename: Primo N
authors.initials: PN
authors.lastname: Lara
authors.affiliation: University of California, Davis, Comprehensive Cancer Center, Sacramento, CA.
authors.forename: Philip C
authors.initials: PC
authors.lastname: Mack
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism*; D019008:Drug Resistance, Neoplasm; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism*; D008297:Male; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D015398:Signal Transduction
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases